Exhibit 10.13


 


[Executive]


 


Dear          ;


 


This letter sets forth
the arrangement between Abbott Laboratories (“Abbott”), Hospira, Inc.
(“Hospira”) and yourself, whereby certain 2004 Hospira benefits shall be paid
to you on an after-tax basis and deposited into your existing grantor trust[s]
which was [were] previously created, or will be newly created, pursuant to your
participation in an Abbott benefit plan and your previous elections thereunder
(“Trust”) .


 


During the period
beginning as of the distribution of Hospira shares to the Abbott stockholders
(the “Distribution”) and ending on December 31, 2004 (the “Transition
Period”), Hospira shall have in place the Hospira 2004 Performance Incentive
Plan, Hospira Supplemental Pension Plan and the Hospira 401(k) Supplemental
Plan.  To the extent that you accrue
benefits under one or more of these Hospira benefit plans with respect to
services rendered to Hospira during the Transition Period and you previously
had, or will have, amounts contributed to your Trust pursuant to corresponding
Abbott plans, payments will be made by Hospira to you and deposited into your
existing Trust, consistent with the 2004 elections you have previously made
under the corresponding Abbott benefit plans, subject to the provisions of the
applicable Hospira plans.  The amounts
paid to your Trust will be net of the maximum taxes required to be withheld
from the plan payments.  The
contributions to your Trust will be made in a similar manner as it was
previously done under the corresponding Abbott plan.


 


Following the Hospira
payment to your Trust, Abbott shall treat such payments as though they were
made pursuant to the corresponding Abbott plan.  Abbott shall remain obligated with respect to all ongoing Trust
related expenses and shall continue to treat the full balance in the Trust as
Abbott plan contributions with respect to annual adjustments and tax gross up
contributions.


 


The transfer of your
employment from Abbott to Hospira in connection with the Distribution shall not
constitute a termination of employment for purposes of distributions under the
applicable Trust.  The “settlement
date,” as that term is used in the Trust documents and applicable payment
election forms, will occur upon your subsequent retirement or other termination
of employment with Hospira and any reference in such documents to the Abbott
Laboratories Annuity Retirement Plan, with respect to the timing of
distributions, shall be deemed to refer to the Abbott/Hospira Transitional
Annuity Retirement Plan (“TARP”). 
Hospira will be obligated to timely notify Abbott of your subsequent
termination of employment and the form of payment of your benefits under the
TARP.


 


Each party agrees to
execute such further documents, if any, required by the trustee of the Trust to
implement this agreement.


 


Please sign this letter
below acknowledging your understanding and agreement with its contents.


 


	
  ABBOTT
  LABORATORIES

  	
  HOSPIRA, INC.

  
	
   

  	
   

  
	
  By: 

  	
   

  	
   

  	
  By: 

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Its: 

  	
   

  	
   

  	
  Its: 

  	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  [Executive]

  	
  Date